February 23, 2026
Not Formula 1. FoundationOne CDx. A month ago, I dropped €3,600 to have my tumor genetically profiled. Today I sat down with my oncologist to review the results. FoundationOne CDx analyzes hundreds of cancer-related genes in tumor tissue to identify driver mutations, biomarkers like MSI and TMB, FDA-approved targeted therapies, and clinical trial matches. It's a DNA-level blueprint of the cancer. My results: KRAS G12V mutation, MSI-Stable, low tumor mutational burden (4 muts/Mb), HRD-negative,…
More